Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2012
10/17/2012CN101301401B Camellia effective ingredients and extracting method and use thereof
10/17/2012CN101208307B Process for preparing amorphous rosuvastatin calcium free of impurities
10/16/2012US8288560 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
10/16/2012US8288541 Piperazine amide derivatives
10/16/2012US8288539 Dipeptidyl peptidase inhibitors
10/16/2012US8288537 Caspase inhibitors and uses thereof
10/16/2012US8288338 Exendin and exendin agonists for eating disorders
10/16/2012US8287898 Compositions and methods for body weight management
10/16/2012US8287873 Vascular endothelial cell growth factor antagonists and uses thereof
10/16/2012CA2589229C 9,10-secopregnane derivatives and medicine
10/16/2012CA2563895C Disalt inhibitors of il-12 production
10/16/2012CA2485681C Ccr9 inhibitors and methods of use thereof
10/16/2012CA2404340C Methods of blocking tissue destruction by autoreactive t cells
10/16/2012CA2393904C Hepoxilin analogs
10/16/2012CA2356257C Insulin-like growth factor (igf) i mutant variants
10/11/2012WO2012138941A1 Compositions comprising glucagon analogs and methods of making and using the same
10/11/2012WO2012138599A2 Hepatocyte growth factor mimics as therapeutic agents
10/11/2012WO2012138212A1 Food composition for intra-operative tube feeding
10/11/2012WO2012138147A2 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof
10/11/2012WO2012138146A2 Composition containing heat-treated powder or extract of glycine soja as active gradient for prevention and treatment of diabetes mellitus and diabetic complications
10/11/2012WO2012137991A1 Pharmaceutical composition for the prevention or treatment of mucolipidosis ii, comprising a lysosomal enzyme as an active ingredient
10/11/2012WO2012137899A1 Parasite suppressing onset of type 2 diabetes
10/11/2012WO2012137163A1 Flour-based functional food
10/11/2012WO2012136699A1 Use of l-carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function
10/11/2012WO2012136603A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
10/11/2012WO2012136221A1 Ortho-fluoro substituted compounds for the treatment of metabolic diseases
10/11/2012WO2012136204A2 Preparation or dietary supplement
10/11/2012WO2012082765A3 Methods for decreasing body weight and treating diabetes
10/11/2012WO2011131707A8 ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
10/11/2012US20120259151 Pyridopyrazine derivatives and their use
10/11/2012US20120259093 Expression of secreted human alpha-fetoprotein in transgenic animals
10/11/2012US20120259022 Pharmaceutical compositions providing enhanced drug concentrations
10/11/2012US20120258996 Novel ligands that modulate rar receptors
10/11/2012US20120258988 Therapeutic or prophylactic agent for diabetes
10/11/2012US20120258982 Adamantyl compounds
10/11/2012US20120258979 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/11/2012US20120258973 Disubstituted heteroaryl-fused pyridines
10/11/2012US20120258967 Pi3 kinase inhibitors and uses thereof
10/11/2012US20120258962 1,3-oxazines as bace1 and/or bace2 inhibitors
10/11/2012US20120258960 Novel multifunctional peptidase inhibitors, especially for medical use
10/11/2012US20120258959 Pyridone gpr119 g protein-coupled receptor agonists
10/11/2012US20120258957 Heterocyclic derivatives
10/11/2012US20120258955 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
10/11/2012US20120258946 Substituted Phenylureas and Phenylamides as Vanilloid Receptor Ligands
10/11/2012US20120258943 Formulations of deoxycholic acid and salts thereof
10/11/2012US20120258938 Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof
10/11/2012US20120258932 Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia
10/11/2012US20120258924 Method of modulating stress-activated protein kinase system
10/11/2012US20120258914 Coacervation process
10/11/2012US20120258913 Glucopyranoside compound
10/11/2012US20120258911 Phenylalkylcarboxylic acid delivery agents
10/11/2012US20120258905 Vitamin receptor drug delivery conjugates for treating inflammation
10/11/2012US20120258184 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and food or beverage
10/11/2012US20120258183 Macronutrient sensitivity
10/11/2012US20120258182 Synergistic compositions and methods
10/11/2012US20120258176 Nanoparticles for protein drug delivery
10/11/2012US20120258170 Pharmaceutical co-crystals of quercetin
10/11/2012US20120258169 Chewable Soft Capsule
10/11/2012US20120258167 Oral pharmaceutical composition
10/11/2012US20120258147 Method for inhibiting angiogenesis
10/11/2012US20120258114 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
10/11/2012US20120258105 Methods and compositions to regulate iron metabolism
10/11/2012US20120258094 Method for treating a rheumatic disease using a soluble ctla4 molecule
10/11/2012US20120258084 Progenitor cells and uses thereof
10/11/2012US20120258080 Pyridopyrazine derivatives and their use
10/11/2012US20120258069 Rgd-binding compounds and methods of use
10/11/2012US20120258043 Linkable Lewis X Analogs
10/11/2012US20120258040 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
10/11/2012CA2832581A1 Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)
10/11/2012CA2832113A1 Hepatocyte growth factor mimics as therapeutic agents
10/11/2012CA2831995A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
10/10/2012EP2508524A2 Indole compound
10/10/2012EP2508513A1 2-pyridone compounds
10/10/2012EP2508503A1 Spiro compounds and pharmaceutical use thereof
10/10/2012EP2508188A1 Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate
10/10/2012EP2508179A1 Use of L-Carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function
10/10/2012EP2507239A1 Azacyclic spiro derivatives
10/10/2012EP2507228A1 Novel spiropiperidine compounds
10/10/2012EP2507222A1 Salacinol and ponkoranol homologues, derivatives thereof, and methods of synthesizing same
10/10/2012EP2506863A1 Method of regulating ppar, obesity related pathways and their associated metabolic impact
10/10/2012EP2506860A1 Dietary fibre composition containing beta-glucan
10/10/2012EP2506717A1 Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions
10/10/2012CN1956734B Multi-vitamin and mineral nutritional supplements
10/10/2012CN1501809B Chronic treatment regimen using glucagon-like insulinotropic peptides
10/10/2012CN1304450B Novel insulin analogs with enhanced zinc binding
10/10/2012CN102725312A Protein agent for diabetes treatment and beta cell imaging
10/10/2012CN102725288A Method for manufacturing a 6-substituted-1-methyl-1H-benzimidazole derivative, and manufacturing intermediate from said method
10/10/2012CN102725264A Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient
10/10/2012CN102725263A Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
10/10/2012CN102724986A Manufacturing method for dried earthworm powder
10/10/2012CN102724982A Pemirolast for the treatment of systemic low grade inflammation
10/10/2012CN102724976A Metabolic imprinting effects of structured lipids
10/10/2012CN102718881A Efficient purification technology for ganoderma lucidum polysaccharide
10/10/2012CN102718870A Insulin bio-sensitizer and application thereof
10/10/2012CN102718868A Fixed point mono-substituted pegylation of Exendin analogue and preparation method thereof
10/10/2012CN102718858A Glucagon-like peptide-1 (GLP-1) analogue monomer and dimer, preparation method therefor and application thereof
10/10/2012CN102718827A Method for separating and purifying ginsenoside Rb3
10/10/2012CN102718759A Heterocyclic CETP inhibitors
10/10/2012CN102718757A 2H-1-benzopyran-2-one compounds with alpha-glucosidase inhibitory activity and medicinal composition of 2H-1-benzopyran-2-one compounds
10/10/2012CN102718727A Arylurea derivative with dual GK/PPAR agonist activities
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 1298